$SIBN

SIBN Q2'26 Earnings: EPS estimate is (0.15) USD

Si-Bone, Inc. (SIBN) is scheduled to report Q2 2026 earnings on Aug. 3 after market close, with results expected at 4:09 PM ET. The consensus outlook cited for the quarter includes revenue of $55.34 million and EPS of -$0.15 (USD).

Original reporting
Published Jul 31, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SIBN Q2'26 Earnings: EPS estimate is (0.15) USD — source image
Decision brief

The 30-second read

$SIBNNeutralMed
01

Why it matters

Traders can use the provided consensus numbers to frame expectations and plan around after-hours volatility on Aug 03.

02

Market read

Event-driven setup for an Aug 03 after-hours earnings print, with consensus expectations of $55.34M revenue and -$0.15 EPS.

03

What to watch

The article does not include guidance, margins, cash burn, or backlog details, which often dominate biotech/medtech earnings reactions beyond the headline EPS and revenue.

Relevance 6/10Novelty 5/10Timing: Aug 03 after the market close earnings release (4:09 PM ET disclosure time).

Background

The piece is an earnings preview for SIBN’s Q2'26 results, including consensus revenue and EPS and the after-hours release time.

Company-level read

Ticker impact

$SIBNNeutralMedium confidence
Context

SIBN is scheduled to announce Q2'26 results Aug 03 after the close, with consensus revenue of $55.34M and EPS of -$0.15.

Expected impact

Moderate two-sided volatility around the Aug 03 after-hours earnings release, driven by the gap versus the -$0.15 EPS and $55.34M revenue expectations.

Evidence & confidence

The article provides only consensus estimates and timing, not actual results or new guidance. That typically increases event-driven volatility but offers limited directional edge without additional qualitative drivers.

Market effects

Limited sector read-through because the article only provides company-specific consensus figures and release timing.

Primarily US small/mid-cap event risk; no cross-market policy or macro linkage is stated.

No global supply chain, regulatory, or geopolitical elements are mentioned.

Counterpoint

If the market already priced in the consensus EPS and revenue, the stock reaction could be muted unless management commentary materially changes expectations.

Key entities

  • SIBN

    SI-BONE, Inc., scheduled to report Q2'26 results on Aug 03 after the close.

Related articles

$EWHighAI 8/10

Weekly Buzz: EW, ABBV, MIRM Score FDA Wins, AZN, NVO Strike Deals; LLY, KOD Report Data

Edwards Lifesciences (EW) received FDA approval for a pediatric heart valve. Ceribell (CBLL) and SI-BONE (SIBN) cleared new software and spinal fusion systems. Teva (TEVA) added a biosimilar to its portfolio. AbbVie (ABBV) and Mirum (MIRM) gained FDA approvals for Parkinson's and rare disease treatments. Merck (MRK) withdrew a lung cancer drug filing. Sanofi (SNY) and Regeneron (REGN) expanded their immunology alliance.

$SIBNHigh

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to t

$TSLAHighAI 9/10

Tesla Still Needs Cars to Fund Robotaxis, Former President Says - Tesla (NASDAQ:TSLA)

Tesla (TSLA) reported Q3 deliveries of 486,532 vehicles, exceeding estimates. Former president Jon McNeill stated the company still relies on car sales to fund robotaxi and robot development, which require significant capital. Energy storage deployments missed expectations. McNeill highlighted Full Self-Driving software as a key driver of vehicle demand. Shares rose over 5% post-report.